Skip to content

Sono-guided Prolotherapy/ Oxygen-ozone/ corticosteroid therapy for the treatment of musculoskeletal Pain in physical and rehabilitation medicine: Interventional pain management for Piriformis: AProspective, randomized, double-blind, Positive control, Multicenter Clinical Trial

Sono-guided Prolotherapy; Oxygen-ozone; corticosteroid therapy for the treatment of musculoskeletal Pain in physical and rehabilitation medicine: Interventional pain management for Piriformis: AProspective, randomized, double-blind, Positive control, Multicenter Clinical Trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100827004641N15
Enrollment
48
Registered
2020-08-04
Start date
2020-01-18
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Piriformis syndrome.

Interventions

Intervention 1: Intervention group A. Intervention 2: Intervention group B:. Intervention 3: Intervention group c:.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
46 Years to 46 Years

Inclusion criteria

Inclusion criteria: Pain and the presence of trigger points in the preformis area for at least 2 months VAS score up 4

Exclusion criteria

Exclusion criteria: Existence of radiculopathy based on clinical examination Appropriate imaging if needed Abscess, fibrosis or any skin infection at the injection sitedisorders7. Pregnancy Existence of a history of physiotherapy or injections in the last 2 months The presence of trigger points in the gluteus medius muscle, which is adjacent to the piriformis Coagulation

Design outcomes

Primary

MeasureTime frame
Local injection of ozone. Timepoint: Baseline. Method of measurement: Specific indexes and sonographic findings.;Corticosteroids. Timepoint: Before injection, one week later and two months after injection. Method of measurement: Specific indexes and sonographic findings.;Prolotherapy. Timepoint: Baseline. Method of measurement: Specific indexes and sonographic findings.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBina Eftekharsadat

Tabriz University of Medical Sciences

pmrrc@tbzmed.ac.ir+98 41 3337 1134

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026